Table 3 Summary of polygenic scores derived from T-cells subsets (CD4+ and CD8+) and CD4:CD8 ratio by chromosome for non-LS sarcoidosis (664 cases and 2,086 controls) using unpruned sets.

From: Common variants of T-cells contribute differently to phenotypic variation in sarcoidosis

CHR

CD4+

CD8+

CD4/CD8 ratio

Nagelkerke R2 (%)

% of explained variance

C-statistic

SCORE P-value

Nagelkerke R2 (%)

% of explained variance

C-statistic

SCORE P-value

Nagelkerke R2 (%)

% of explained variance

C-statistic

SCORE P-value

Baseline

17.40%

0.00%

0.73

1.23E-73

17.40%

0.00%

0.73

1.23E-73

17.40%

0.00%

0.73

1.23E-73

1

17.10%

0.30%

0.74

1.17E-01

17.05%

0.35%

0.73

2.14E-01

16.97%

0.43%

0.73

9.48E-01

2

17.03%

0.37%

0.74

2.93E-01

17.29%

0.11%

0.74

1.38E-02

17.11%

0.29%

0.74

1.03E-01

3

17.04%

0.36%

0.73

2.49E-01

16.99%

0.42%

0.73

6.10E-01

16.98%

0.43%

0.73

8.30E-01

4

17.04%

0.36%

0.74

2.51E-01

17.06%

0.35%

0.74

2.08E-01

16.99%

0.42%

0.73

6.28E-01

5

16.97%

0.43%

0.73

9.23E-01

17.17%

0.24%

0.74

5.55E-02

17.15%

0.26%

0.74

7.10E-02

6

17.81%

0.41%

0.74

6.16E-05

16.98%

0.43%

0.73

8.46E-01

17.10%

0.30%

0.73

1.16E-01

7

16.98%

0.43%

0.73

8.57E-01

17.07%

0.34%

0.73

1.79E-01

17.00%

0.40%

0.73

4.49E-01

8

17.01%

0.39%

0.73

3.83E-01

16.97%

0.43%

0.73

9.93E-01

16.99%

0.41%

0.73

5.76E-01

9

17.03%

0.38%

0.74

3.23E-01

16.98%

0.42%

0.73

6.46E-01

16.97%

0.43%

0.73

8.73E-01

10

16.99%

0.42%

0.73

6.32E-01

17.30%

0.11%

0.74

1.35E-02

17.29%

0.12%

0.74

1.47E-02

11

16.98%

0.43%

0.73

8.10E-01

16.99%

0.41%

0.73

5.38E-01

17.03%

0.37%

0.73

2.94E-01

12

17.01%

0.40%

0.74

4.42E-01

16.99%

0.41%

0.73

5.31E-01

17.07%

0.34%

0.74

1.80E-01

13

16.99%

0.42%

0.73

6.11E-01

17.08%

0.32%

0.74

1.52E-01

17.11%

0.29%

0.74

1.03E-01

14

17.03%

0.38%

0.74

3.06E-01

17.04%

0.36%

0.74

2.56E-01

16.98%

0.43%

0.73

8.01E-01

15

17.05%

0.36%

0.73

2.46E-01

17.00%

0.41%

0.74

5.04E-01

17.17%

0.24%

0.74

5.59E-02

16

17.08%

0.32%

0.74

1.51E-01

17.00%

0.41%

0.74

5.20E-01

17.23%

0.18%

0.74

2.87E-02

17

16.99%

0.42%

0.73

6.02E-01

17.06%

0.35%

0.74

2.05E-01

17.00%

0.41%

0.74

4.85E-01

18

17.04%

0.36%

0.74

2.63E-01

17.07%

0.33%

0.74

1.76E-01

16.98%

0.43%

0.73

7.85E-01

19

16.98%

0.43%

0.73

7.95E-01

16.97%

0.43%

0.73

9.93E-01

16.97%

0.43%

0.73

9.82E-01

20

16.98%

0.42%

0.74

6.96E-01

16.97%

0.43%

0.73

9.85E-01

16.99%

0.41%

0.73

5.29E-01

21

17.00%

0.40%

0.73

4.55E-01

17.03%

0.37%

0.74

2.96E-01

17.00%

0.40%

0.74

4.43E-01

22

16.99%

0.42%

0.73

6.25E-01

17.00%

0.40%

0.73

4.70E-01

17.12%

0.29%

0.74

9.97E-02

  1. CHR = chromosome; P-value is the statistical significance appertaining to the derived polygenic score profile (SCOREprofile).